Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need.
$1.07+2.88%
报价 2026-11-06
市值
$96.5M
EV
$93.1M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -33.1%
$0.94$1.60
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| VANIVivani Medical, Inc. | $96.5M | +2.9% | -100.0% | 0% | – | – | – | |
| RCELAVITA Medical, Inc. | $412.1M | +5.8% | – | 81.6% | – | – | – | |
| ORMPOramed Pharmaceuticals Inc. | $160.6M | -0.8% | -40.0% | 0% | 1.9x | 2.4x | – | |
| CRDLCardiol Therapeutics Inc. | $120.1M | +7.4% | – | 0% | – | – | – | |
| MBOTMicrobot Medical Inc. | $74.6M | +3.7% | +4900.0% | -9.5% | – | – | – | |
| HYPRHyperfine, Inc. | $65.5M | +5.0% | +50.7% | 51.4% | – | – | – | |
| IMAImageneBio Inc | $46.6M | -1.4% | 0.0% | 0% | – | – | – | |
| NSPRInspireMD, Inc. | $32.4M | +8.9% | – | 18.1% | – | – | – | |
| 同行中位数 | – | – | +25.4% | 0% | 1.9x | 2.4x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。